Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Infinity Pharmaceuticals Inc (NASDAQ:INFI)

2.04
Delayed Data
As of 1:00pm ET
 -0.02 / -0.97%
Today’s Change
0.93
Today|||52-Week Range
3.84
+51.11%
Year-to-Date

Today’s Trading

Previous close2.06
Today’s open2.02
Day’s range1.99 - 2.07
Volume248,119
Average volume (3 months)2,042,840
Market cap$104.4M
Dividend yield--
Data as of 1:00pm ET, 11/24/2017

Growth & Valuation

Earnings growth (last year)+76.72%
Earnings growth (this year)--
Earnings growth (next 5 years)+101.00%
Revenue growth (last year)-82.83%
P/E ratioNM
Price/Sales3.58
Price/Book1.26

Competitors

 Today’s
change
Today’s
% change
ATNMActinium Pharmaceuti...+0.02+2.38%
GNMXAevi Genomic Medicin...+0.02+1.60%
OVASOvaScience Inc+0.02+1.47%
JNPJuniper Pharmaceutic...-0.05-0.95%
Data as of 4:00pm ET, 11/24/2017

Financials

Next reporting dateFebruary 27, 2018
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$18.7M
Annual profit (last year)-$30.1M
Net profit margin-160.77%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Adelene Q. Perkins
President &
Treasurer
Lawrence E. Bloch
Corporate headquarters
Cambridge, Massachusetts

Forecasts